SAMANTHA WINDATT: Open Payments
NPI 1124457890 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 59 payments from 16 companies in 2025. Trend: 2023 $1,966 · 2024 $1,253 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $266 |
| Endo USA, Inc. | 8 | $212 |
| COLOPLAST CORP | 6 | $202 |
| ABBVIE INC. | 17 | $194 |
| PFIZER INC. | 5 | $106 |
| Janssen Biotech, Inc. | 2 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| TOLMAR, INC. | 2 | $47 |
| Boston Scientific Corporation | 2 | $44 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
Products named: Luja Coude, BOTOX, XIAFLEX, GEMTESA, ORGOVYX, XTANDI, PLUVICTO, AVEED.
Industry payments across AZ — which companies pay providers there.
